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The Sec61 complex is the major protein translocation channel of the endo-
plasmic reticulum (ER), where it plays a central role in the biogenesis of
membrane and secretory proteins. Whilst Sec61-mediated protein transloca-
tion is typically coupled to polypeptide synthesis, suggestive of significant
complexity, an obvious characteristic of this core translocation machinery
is its surprising simplicity. Over thirty years after its initial discovery, we
now understand that the Sec61 complex is in fact the central piece of an
elaborate jigsaw puzzle, which can be partly solved using new research
findings. We propose that the Sec61 complex acts as a dynamic hub for co-
translational protein translocation at the ER, proactively recruiting a range
of accessory complexes that enhance and regulate its function in response
to different protein clients. It is now clear that the Sec61 complex does not
have a monopoly on co-translational insertion, with some transmembrane
proteins preferentially utilising the ER membrane complex instead. We also
have a better understanding of post-insertion events, where at least one
membrane-embedded chaperone complex can capture the newly inserted
transmembrane domains of multi-span proteins and co-ordinate their
assembly into a native structure. Having discovered this array of Sec61-as-
sociated components and competitors, our next challenge is to understand
how they act together in order to expand the range and complexity of the
membrane proteins that can be synthesised at the ER. Furthermore, this
diversity of components and pathways may open up new opportunities for
targeted therapeutic interventions designed to selectively modulate protein
biogenesis at the ER.
Introduction
Integral membrane proteins are often anchored into
their host membrane via one or more hydrophobic
polypeptide segments, or transmembrane domains
(TMDs), that span the entire width of the phospho-
lipid bilayer. These so-called ‘transmembrane’ proteins
(TMPs) represent ~ 25% of human genes, are diverse
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in structure and perform a plethora of essential cellular
functions [1]. The endoplasmic reticulum (ER) is a
major site for the biogenesis of such integral membrane
proteins, acting as their entry point into the secretory
pathway, an elaborate network tasked with the synthe-
sis, folding and transport of both membrane and secre-
tory proteins (Fig. 1A) [2,3]. Given the molecular
crowding of the cytosol and the biophysical constraints
of the lipid bilayer, most TMPs enter a dedicated ER
targeting pathway(s) as soon as an appropriate subcel-
lular targeting signal has emerged from the ribosome.
Upon arrival at the ER, these nascent polypeptides are
threaded into and across its membrane via specialised
protein translocation channels that typically act con-
comitantly with translation [4].
Amongst these ER translocation channels, the het-
erotrimeric Sec61 complex (a, b, c subunits), or Sec61
‘translocon’ [5], is the principal protein-conducting
channel through which secretory proteins are fully
translocated across the ER membrane. TMPs also
access the Sec61 complex, however, in contrast to
secretory proteins, they are only partially translocated,
with their TMD(s) exiting the Sec61 complex via a lat-
eral gate. This enables stable membrane integration
and thereby constrains their membrane topology as
they navigate the secretory pathway towards the
plasma membrane. Single-span TMPs can be grouped
into different types based on their structural features
and the location of their N and C termini relative to
the ER membrane (Fig. 1B). Here, we will classify
them as type I, type II or type III TMPs and tail-an-
chored (TA) proteins (Fig. 1B; [6]). Based on the fea-
tures of their first TMD, this characterisation can, in
principle, also be extrapolated to multi-span TMPs
(type I-like, type II-like, type III-like). However, given
that the membrane insertion of multiple TMDs is not
necessarily sequential and may also be co-operative
[7,8], such an approach may be of limited use when
trying to understand the biogenesis of multi-span
TMPs.
It is increasingly clear that TMP biogenesis at the
ER is a substrate-selective and mechanistically diverse
process that involves a range of molecular machines
well beyond the canonical Sec61 translocon [9]. Herein,
we review the rapidly expanding field of co-transla-
tional membrane protein biogenesis at the mammalian
ER; that is, when membrane insertion is concomitant
with ribosomal polypeptide synthesis. Focussing on
the mechanisms of ER targeting, together with protein
translocation across, and TMD insertion into, the ER
membrane, where relevant, we draw upon molecular
details obtained in bacterial and yeast systems so as to
gain prospective insight into mammalian mechanisms
of co-translational TMP biogenesis that are yet to be
fully elucidated.
ER membrane targeting: the SRP-
delivery system
Within the arsenal of ‘accessory components’
employed by the Sec61 complex [9], the signal recogni-
tion particle-(SRP) and its ER membrane-localised
cognate binding partner, the SRP receptor, constitute
the first key players that are encountered by the major-
ity of proteins destined for the secretory pathway.
Together, these complexes mediate protein targeting to
the ER [4], typically by virtue of an N-terminal
hydrophobic stretch of amino acids [13], or signal
sequence, that acts as a ‘molecular postcode’ and, in
many cases, is cleaved [11] from the newly synthesised
polypeptide once it is committed to membrane translo-
cation and/or insertion.
Not all polypeptides that are destined for the ER
are equipped with a so-called cleavable N-terminal sig-
nal sequence (Fig. 1B). Hence, in the case of type II
and III TMPs their hydrophobic TMD(s) act as ‘sig-
nal-anchor’ sequences, emulating the functions of N-
terminal ER signal sequences and targeting nascent
TMPs to the ER prior to their integration into the
membrane bilayer [7,8]. Thus, whether cleavable or
not, these hydrophobic regions within TMPs act as
‘signal flares’, efficiently recruiting and interacting with
the SRP at an early stage during the synthesis of the
nascent polypeptide. Hence, the SRP-delivery system
predominantly operates co-translationally, targeting a
range of structurally diverse single- and multi-span
TMP clients to the ER for co-translational membrane
insertion. Notable exceptions include TMPs whose ER
targeting and integration occurs after protein synthesis
is completed (post-translationally), as best exemplified
by the TA proteins (cf. Fig. 1B) [14–16]. In yeast, the
proteome-wide effects of rapid SRP depletion suggest
it is essential for the efficient ER targeting of TMPs
utilising their TMDs as signal-anchor sequences [17].
In contrast, SRP is only required for the ER delivery
of ~ 14% of yeast proteins with cleavable N-terminal
signal sequences [17]. Likewise in bacteria, SRP is
essential for membrane targeting of inner-membrane
proteins utilising signal-anchor sequences. However, it
is dispensable for the targeting of many secreted pre-
cursor proteins with N-terminal signal sequences
[18,19]. Although it is generally assumed that SRP
plays a wider role in the ER targeting of proteins that
bear N-terminal signal sequences in mammalian cells,
proteome-wide analyses that directly test this hypothe-
sis are presently lacking.
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Fig. 1. Accessing the secretory pathway via Sec61: ‘many hands make light work’ (A) Newly synthesised secretory proteins and TMPs are
targeted to and translocated into the ER lumen in order to enter the secretory pathway (green arrow). Mature proteins that have progressed
through the Golgi apparatus are then delivered to the plasma membrane (PM) where they may be either incorporated or secreted (red
arrow). (B) Representative structures of four classes of single-span TMPs: type I TMPs are equipped with an N-terminal signal sequence
(s.s.), a lumenally translocated N terminus and a stop-transfer sequence (ST) which acts as the TMD; type II and type III TMPs do not
possess an N-terminal signal sequence and have a signal-anchor sequence (SA) and, respectively, translocate their C and N termini into the
ER lumen; tail-anchored (TA) proteins are topologically and structurally similar to type II TMPs, but their extremely short C-terminal region
necessitates that their insertion into the ER occurs post-translationally. (C) The Sec61 complex can call on a diverse repertoire of additional
cellular machineries to facilitate various aspects of its role in co-translational TMP biogenesis including: ER targeting (top left inset), Sec61
channel gating (top right inset), TMD insertion and TMD folding/assembly (bottom left inset). Additional events, such as N-linked
glycosylation (via OST, oligosaccharyltransferase complex), signal sequence cleavage (via SPC, signal peptidase complex) and ER chaperone-
mediated lumenal folding (see BiP, binding immunoglobulin protein; Grp94; PDI, protein disulphide isomerase; ERp57; CRT, calreticulin), are
also coupled to the actions of the Sec61 translocon (bottom right inset), and we direct the reader to recent articles that review these
processes [9–12]. Schematics are illustrative only and are not drawn to scale.
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In mammals, the cytosolic targeting factor SRP is a
multimeric complex of six protein subunits assembled
onto a core 7S RNA (Fig. 2A) [20–22], and is first
recruited by signal sequences/anchors from within the
ribosomal exit tunnel [23,24]. As the exit tunnel typi-
cally shields the first ~ 40 amino acid residues of nas-
cent polypeptide chains from the cytosol [25], such early
SRP recruitment is presumed to occur via ribosome-
nascent chain (RNC)-induced structural rearrangements
within the actively translating ribosome [26]. Once
recruited, SRP binds to the ribosome at a location that
is partly occupied by the nascent polypeptide-associated
complex (NAC); a co-translational chaperone that
enhances SRP-dependent targeting by increasing the
fidelity of signal sequence recognition by SRP [27] and
preventing the promiscuous interaction of ribosomes
with Sec61 [28]. Thus, co-translationally bound and
NAC-regulated SRP [27] is suitably poised to ‘scan’
and engage ER signal sequences/anchors as soon as
they emerge from the ribosome [22,24,29,30].
Cellular levels of SRP are significantly lower than
the near stoichiometric concentrations of ribosomes
and NAC [27]. Thus, if an ER targeting signal is not
encountered quickly, SRP rapidly dissociates from the
RNC complex, effectively cycling on and off ribo-
somes in search of a substrate signal sequence [31]. In
the case of timely SRP engagement by an ER signal
sequence/anchor, a process that may be enhanced by
certain nonoptimal, ‘translation slowing’ mRNA
codons located downstream of the signal sequence
coding region [32], ribosomal translation is transiently
stalled by the Alu domain of SRP [33,34; see Fig. 2B,
left]. This translational stalling effectively maintains
the nascent chain in a ‘translocation competent’ state
during the time window available for successful ER
delivery, as dictated by the limiting number of SRP
receptor targeting sites [33].
Once at the membrane, and co-ordinated by the
concerted actions of two GTPases, the signal sequence
binding subunit of SRP (SRP54) and the membrane-
tethered alpha subunit of the SRP receptor (SRa), the
now quiescent SRP-RNC complex engages the SRP
receptor [35]. Complex formation between SRP and its
receptor leads to repositioning of both SRP54 and
SRa relative to the SRP RNA from the so-called
‘proximal’ site to an alternative ‘distal’ site (Fig. 1B).
This generates a ‘prehandover complex’, where the
Sec61 binding site of the ribosome that was previously
occluded by SRP54 now becomes accessible, whilst
also blocking GTP hydrolysis by SRP54 and SRa.
Subsequent arrival of this complex at the Sec61
translocon triggers handover of the ribosome and nas-
cent chain from the SRP/SRP receptor complex con-
comitantly with GTP hydrolysis by SRP54 and SRa.
Posthandover, and following the opening of the Sec61
translocon (see Gating of the Sec61 complex), transla-
tion is resumed as membrane translocation and/or
membrane insertion of the nascent polypeptides takes
place (Fig. 2B, right) and SRP is recycled for addi-
tional rounds of ER targeting [22].
Since the ‘signal hypothesis’ was postulated [36–39],
the mammalian SRP-delivery system outlined above
Fig. 2. Getting there in one piece: an SRP- and SGTA-assisted route to the ER membrane (A) A representation of bacterial and mammalian
SRP complexes indicating conserved RNA helices [54]. Assembled on the highly base-paired 7SL SRP RNA, the six mammalian SRP
proteins are organised into a functionally independent Alu domain, responsible for translational pausing, and an S domain which mediates
SRP binding to signal sequences/anchors and the SRP receptor. Subunits of the S domain are essential for SRP function, whereas those of
the Alu domain are dispensable [22]. (B) SRP-dependent ER membrane targeting involves distinct SRP-RNC-mediated events. The RNC with
a signal sequence/anchor is first bound by SRP. SRP next associates with the SRa subunit of the SRP receptor via its SRP54 subunit,
located at a ‘proximal site’ of the SRP RNA that is close to the ribosomal exit tunnel. Subsequent interaction of the SRP receptor with the
Sec61 translocon permits a structural rearrangement, in which SRa and SRP54 are relocated to a conserved ‘distal site’ in the SRP RNA
that primes for the handover of signal sequences to the Sec61 translocon. Signal handover, most likely coupled with the hydrolysis of GTP,
drives the dissociation of SRP from the SRP receptor [22]. Hydrophobic targeting signals are depicted as signal anchors only (and not signal
sequences) for simplicity. (C) A model of SRP-dependent targeting to the ER membrane: SRP ‘scans’ the emerging nascent chain of a
translating ribosome for hydrophobic targeting signals, binds the ribosome-nascent chain complex (RNC) and delivers it to the ER membrane
via its interaction with the SRP receptor (RNC-ER membrane docking), prior to membrane insertion [22]. If translational pausing is
inefficient, or there is only a short linker between two transmembrane domains, SGTA may be recruited to protect the second hydrophobic
region until it is membrane inserted (left). If such regions of hydrophobicity emerge from the RNC and remain un-chaperoned (right), these
nascent chains may become ubiquitinated and hence targeted for proteasomal degradation [44]. For clarity, only a membrane protein with a
short linker between two signal-anchor sequences is depicted as an example. (D) Three ways to the ER. If a TMD is located at the N
terminus or towards the middle of the protein, TMPs are targeted to the ER via SRP as described in parts A-C. However, if a TMD is
located at the C terminus, TMPs are targeted post-translationally to the ER via the mammalian equivalent (TRC40) of the GET pathway in
yeast [14]. Alternatively, hSnd2, the human orthologue of a component of the SND pathway in yeast [47], is involved in the biogenesis of
TMPs whose TMD is located in the mid to C-terminal region of the protein. hSnd2 additionally demonstrates redundancy with the SRP and
TRC40 pathways.
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has been extensively characterised [22,40]. Neverthe-
less, novel aspects of SRP-mediated co-translational
delivery to the ER continue to emerge. For example, it
has been suggested that SGTA [41], a cytosolic quality
control component involved in the post-translational
targeting of TA proteins to the ER [14,41–43] also
contributes to co-translational ER targeting. Hence,
SGTA may facilitate the biogenesis of TMPs contain-
ing two or more closely spaced hydrophobic signals by
binding prematurely exposed TMDs that do not
recruit the substoichiometric SRP [44] (Fig. 2C). In
this way, the actions of SGTA would complement the
ER targeting role of SRP by shielding potentially vul-
nerable TMDs in the nascent polypeptide from inap-
propriate, and possibly damaging, interactions [44].
Such recruitment of SGTA thereby protects nascent
membrane proteins from potential proteasomal degra-
dation until they engage the Sec61 complex and initi-
ate membrane insertion (Fig. 2C) [44]. Exactly how
SGTA is recruited to and associates with the ribosome
and/or other ribosome-associated chaperones such as
NAC [45], why it does not compete with SRP despite
its comparative cytosolic abundance (~ 1 µM versus
~ 5–10 nM) [43,46] and how it is released upon delivery
to the ER membrane are all questions that remain to
be answered.
Despite the range of precursor proteins that are
catered for by the SRP-delivery system, at least two
other ER targeting pathways are operational in the
cytosol: a mammalian version [16] of the co-transla-
tional, SRP-independent or, ‘SND’ pathway first iden-
tified in yeast [47]; and a post-translational route for
TA protein biogenesis known as the TRC40 pathway
in mammals [14]. Whilst these pathways function in
parallel, they are also most likely overlapping and/or
partially redundant in terms of their substrate speci-
ficity. In principle, SRP typically caters for signal
sequences/anchors that are located at or near the N
terminus of nascent polypeptides, SND favours signal
anchors that are more central and TRC40 deals with
C-terminal tail anchor sequences (Fig. 2D) [17,47,48].
Only one mammalian orthologue of the three compo-
nents which make up the SND pathway in yeast has
been identified to date [16,47]. However, this compo-
nent, known as TMEM208 or hSnd2 [49], has been
implicated in the Sec61-mediated biogenesis of short
secretory proteins [50] and single- and multi-span
TMPs [16,51,52], with the wider hSnd2/SND targeting
pathway able to compensate for an absence of the
SRP or TRC40/GET pathways in yeast and mammals
[16,47,51]. The partial redundancy of these three ER
targeting pathways (see [17,47]), which most likely
allows cells to efficiently target membrane proteins
under a wide range of physiological conditions and/or
external stresses, probably explains why the hSnd2/
SND pathway remained undiscovered for so long [48].
Whilst bacteria typically contain only one location,
the inner membrane, to which newly synthesised pro-
teins are delivered, mammalian SRP must correctly
discriminate between the multiple membrane systems
that are accessible from the eukaryotic cytosol. When
compared to its bacterial equivalent, mammalian SRP
displays not only greater structural complexity
(Fig. 2A) but also increased functional complexity, as
evidenced by its early recruitment to the nascent chain,
regulation by the NAC complex and capacity to
induce a translational arrest. When combined with the
‘fail-safe’ option provided by SGTA recruitment, we
speculate that this additional complexity of eukaryotic
SRPs has most likely evolved to enhance the specificity
of, and lengthen the window for, nascent chain target-
ing to the ER membrane; a feat of increasing impor-
tance for TMPs containing multiple TMDs located
after the initial ER signal sequence that may even
require additional rounds of SRP-mediated targeting
to the ER [17,19,53].
We further suggest that in the event that SRP fails to
engage the TMD of a protein client, whether as a con-
sequence of a nonfunctional SRP-delivery pathway, a
more C-terminal location of its ER targeting signal or
for some other reason, the hSnd2/SND pathway pro-
vides an alternative and/or additional system to ensure
that co-translational protein clients continue to be tar-
geted to the ER membrane. We anticipate that uncover-
ing the mechanistic details of the hSnd2/SND pathway
will help to delineate the extent of the substrates that it
caters for, why SRP ‘loses’ its ability to engage TMDs
as a polypeptide chain extends and whether the hSnd2/
SND pathway integrates with the SRP-dependent deliv-
ery pathway at the ER membrane.
Gating of the Sec61 complex
Following signal sequence/anchor-mediated SRP-de-
pendent delivery and transfer of RNCs to the Sec61
complex (cf. Fig. 2), these hydrophobic targeting sig-
nals perform a second key action to fulfil their role as
an ‘ER-entry tag’; they must open the Sec61 channel.
Organised into two distinct halves, with TMDs 1–5
and 6–10 surrounding a central pore (Fig. 3A), the
hourglass-shaped conduit of Sec61a appears empty on
the cytosolic side of the ER membrane whereas a ring
of hydrophobic residues, known as the ‘plug domain’,
seals the ER lumenal side of the pore [5,55,56], effec-
tively preventing the free movement of small molecules
across the Sec61 translocon when inactive (see [57]).
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Opening of the Sec61 channel involves three major
steps. First, the channel is primed to open via the
docking of RNCs to the Sec61 complex (Fig. 3Ai).
Secondly, docking-induced conformational changes
‘crack’ the cytosolic end of the lateral gate (comprised
by TMDs 2, 3, 7 and 8) which facilitates the engage-
ment and intercalation of the signal sequence/anchor
between TMDs 2 and 7. Thirdly, the signal sequence/
anchor-mediated displacement of TMD2 finally results
in movement of the plug domain and opening of the
lateral gate (Fig. 3Aii) [5,55,56]. In situ studies of the
native Sec61 translocon suggest that the lateral gate
can be opened by ribosome binding alone, even in the
absence of a nascent chain [58], although in the case
of bacterial SecYEG [59] the presence of a signal
sequence on a nascent chain enhances opening of the
equivalent lateral gate [60]. These conformational
changes enable co-translational movement of the grow-
ing polypeptide chain across the membrane and into
the ER lumen (Fig. 3Aiii,iv) [5,55,56]. In contrast to
these actively translocated hydrophilic regions of
polypeptide, hydrophobic targeting signals are laterally
inserted into the lipid bilayer via the lateral gate. In
the case of N-terminal signal sequences, they are
cleaved from the nascent chain by the signal peptidase
complex (SPC) [11] (Fig. 3Aiv) and, ultimately, subject
to further processing and/or degradation by signal
peptide peptidase [61]. In contrast, signal-anchor
sequences form a stable membrane tether for the newly
synthesised TMPs. Following translation termination
and the exit of newly synthesised polypeptides from
the channel, the ribosome dissociates from the Sec61
complex and the Sec61a plug domain returns to its
original position (Fig. 3Av).
The central role of the Sec61 translocon during the
biogenesis of secretory proteins, type I and type II
TMPs has been well established for many years
(Fig. 3A,B; see Membrane insertion via the EMC for
type III TMPs). However, there is now a growing body
of evidence that signal sequences can provide an addi-
tional, as yet poorly defined, level of control during
membrane translocation [62]. Highly diverse in terms
of their hydrophobicity, length, charge and specific
amino acid composition [8,13,63], ER targeting signals
appear to regulate the opening, or ‘gating’ of the Sec61
translocon [62], particularly since SRP effectively caters
for targeting signals seemingly irrespective of their
intrinsic ability to gate the translocon which, in some
cases, is ‘inefficient’ and ‘slow’ (Fig. 3C) [64,65].
The defining structural feature of an archetypically
efficient and ‘strongly gating’ signal sequence appears
to be that its core h-region (Fig. 3D) is of sufficient
hydrophobicity to successfully engage with, and insert
‘head-on’ into, the Sec61 translocon (Fig. 3A, stage ii)
and then subsequently re-orientate to form a hairpin
conformation within the channel (Fig. 3A, stage iii).
During both of these apparently discrete stages, the
RNC is subject to a distinct force that pulls the nas-
cent chain away from the ribosome (Fig. 3Ci) [64]. In
contrast, if an ‘inefficient’ signal sequence is appended
to the same polypeptide, the nascent chain experiences
a single, weaker pulling force that reflects its inability
to successfully engage the translocon and undergo in-
channel re-orientation (Fig. 3Ci) [64]. We speculate
that hydrophobic signal-anchor sequences [66,67],
some of which can also reorient inside the Sec61
translocon [68], will be subject to pulling forces com-
parable to those experienced by signal sequences dur-
ing their membrane insertion at the ER [65,69].
Likewise, it seems plausible that the profiles and
strength of the pulling forces experienced by signal
sequences and/or signal anchors may be influenced by
the drivers and determinants of signal orientation/
TMD topology, such as the ‘positive-inside’ rule, the
degree of N-terminal folding and, perhaps, even the
lipid composition of the bilayer [7,8].
In cases where inefficient signal sequences (see [70])
and/or signal anchors require extra help to gate the
translocon, the Sec61 complex may employ ‘gating
assistants’. Hence, the tetrameric TRAP (translocon-
associated protein) complex, composed of a, b, c and
@ subunits [71–73], and/or the Sec62/Sec63 proteins
[74] (Fig. 3D), contribute to the second pulling event
that occurs during secretory protein translocation
(Fig. 3Cii) [75]. Despite subtle differences in the fea-
tures that facilitate their recruitment (Fig. 3D), these
gating assistants exhibit a common propensity to assist
signal sequences/anchors that are of lower hydropho-
bicity [72,74] and/or contain clusters of positive charge
in regions of polypeptide that must be translocated
[74–76]. Furthermore, given that different gating assis-
tants can contribute to the efficient translocation of
the same protein substrate, whether a secretory protein
or TMP (Fig. 3Ei, Tables 1–4) [74], and cellular levels
of TRAP-b are upregulated following depletion of
Sec62 [74], it seems likely that the TRAP complex and
Sec62/Sec63 perform overlapping, but nonidentical,
functions during Sec61-mediated protein translocation
[62].
Such a notion is supported by the behaviour of the
mammalian prion protein (PrP) during its ER translo-
cation [75] where TRAP is required for both signal
sequence engagement with Sec61 and its in-channel
inversion, whereas Sec62/63 only influence the latter
event, and to a lesser extent [75] (see Fig. 3cii). Thus,
it appears that Sec62/63 supports the translocation of
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polypeptides with suboptimal ER targeting features
that may first be recognised by the cytosolic portion of
TRAP [76], prior to TRAP-mediated opening of the
Sec61 complex [72,75–78]. Previous studies established
that Sec62/63 contribute strongly to Sec61 gating dur-
ing the post-translational translocation of certain sub-
strates, including short secretory proteins [50].
However, structural studies strongly suggest that in
order to stabilise RNCs that co-translationally engage
the Sec61 translocon, either alone [5], or in its TRAP-
assisted mode [78], the Sec62/63 complex must adopt a
different conformation to its posttranslational one
[9,79–81].
By subjecting a broader range of TRAP- and Sec62/
63-dependent clients of the Sec61 translocon [72,74] to
detailed force-pulling studies [64,65,69,75,76], it should
be possible to discover mechanistic detail about these
gating assistants that is currently lacking. Currently
unanswered questions include: is the constitutively
Sec61-bound TRAP complex [78] the only ‘gating
assistant’ capable of exerting a pulling force on RNCs
(see [75]); can the Sec62/63 complex compensate for
the loss of TRAP-mediated assistance; is TRAP- and/
or Sec62/63-assisted translocation used to regulate the
flux of protein substrates through the Sec61 translocon
[72,74]? Likewise, although the translocating chain-as-
sociated membrane (TRAM1) protein is closely associ-
ated with the active Sec61 translocation complex [7,8],
a recent ‘global’ analysis suggests that it is not a gating
assistant [82]. Rather it seems that TRAM1 may facili-
tate the egress of hydrophobic regions from the Sec61
lateral gate into the phospholipid bilayer [82], a possi-
bility that clearly merits further exploration. Answer-
ing these questions may also help us to finally
reconcile the long-standing enigma surrounding the
broad sequence diversity that is seen across ER target-
ing signals [13].
Membrane insertion via the EMC
Analogous to the recruitment of ‘gating assistants’ by
ER targeting signals that the Sec61 complex finds chal-
lenging, the multisubunit ER membrane complex
(EMC) (Fig. 4A) provides a membrane insertase for
TMDs that also appear to be more ‘demanding’ of the
ER translocon [83,84]. The EMC was first implicated
in membrane protein biogenesis when gene disruption
of its subunits was found to have pleiotropic effects on
the expression of multi-span TMPs in several species
[85–88]. Multi-span TMPs were subsequently found to
be significantly enriched amongst putative EMC-de-
pendent protein clients (Fig. 4A, Table 5) [89,90], and
the EMC was also identified as an ER membrane
insertase that can facilitate the post-translational inser-
tion of certain TA proteins [15,91]. In light of several
recent structural studies, we now have a better
Fig. 3. ‘With a little help from my friends’: TRAP and/or Sec62/63-assisted gating of Sec61 (A) Schematics of the heterotrimeric Sec61
complex (a, b, c) and the regulation of Sec61a via its plug domain and lateral gate during the co-translational translocation of secretory
proteins [5,9]. Schematics are not drawn to scale. (B) Models for the Sec61-mediated insertion of type I and type II single-pass TMPs. (Bi)
For type I TMPs, a cleavable N-terminal signal sequence enters the Sec61 translocon ‘headfirst’ and is then inverted allowing the
subsequent stop-transfer sequence to become laterally inserted as a TMD with an Nexo/Ccyt topology [8]. (Bii) The Ncyt/Cexo topology of type
II TMPs necessitates that they are membrane inserted in the opposite orientation; this may be achieved either by the ‘headfirst’ insertion of
a signal-anchor sequence followed by its inversion within the Sec61 translocon (shown in brackets) or via a ‘hairpin integration’ mechanism
whereby the signal-anchor engages the translocon in a looped conformation [8]. (C) Schematic overview of the pulling forces experienced
by; (Ci) the protein substrate preprolactin equipped with its normal, archetypically strong, signal sequence (PPL, black solid line) versus its
replacement with an inefficient signal sequence (*PPL, red dashed line; see [64]); (Cii) the Prion protein (PrP) in control cells (red solid line)
and cells depleted of the Sec62/63 (purple dashed line) or the TRAP complex (green dashed line) [75]. (D) TRAP- and/or Sec62/63-
dependent cleavable signal (orange) or signal-anchor (yellow) sequences typically include reduced hydrophobicity in the signal and/or clusters
of positive charge in the early mature domain [72,74,75]. Cleavable signal sequences are N-terminal and typically composed of three
regions: a polar n-region that facilitates signal sequence insertion/inversion at the ER translocon (hatched orange section), a central
hydrophobic h-region that is recognised by SRP (plain orange) and a polar C-terminal region that contains the site for signal sequence
cleavage (dotted orange). Other features of ER signal sequences that necessitate a Sec61-‘gating assistant’ include a high glycine/proline
content (TRAP complex) [72], a longer core h-region (Sec62/63 [74]) and regions of decreased polarity (Sec62/63; [74]). Whilst favouring
different groups of clients, the roles of the TRAP complex and Sec62/63 may be partially redundant. (E) Classification of membrane and
secretory protein clients of Sec62, Sec63 and TRAP based on previous global studies [72,74]. (Ei) Proteins that were negatively affected by
the absence/depletion of one or more of Sec62, Sec63 and TRAP were classified (see Eii) as secretory proteins, single-span TMPs (type I,
type II, type III, TA protein, undefined) or multi-span TMPs (type I-like, type II-like, type III-like, undefined) based on their features and the
topology of their first TMD. The proportion of the putative clients that belong to each of these groups is shown as a percentage of the total
number of proteins (n) that were a negatively affected in each case: Sec62 (n = 84), Sec63 (n = 56) and TRAP (n = 61) (Tables 1–4).
Proteins that do contain an ER targeting sequence and any subunits of Sec61 ‘gating assistant’ were discounted from the analysis.
Figure 3D has been reproduced from Ref. [62].
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understanding of how the evolutionarily conserved
EMC acts in concert with the Sec61 complex to per-
form two important, yet apparently discrete, roles dur-
ing co-translational TMP biogenesis [92]. Firstly, the
EMC acts as a membrane insertase that enables the
stable integration of certain types of TMD into the
lipid bilayer [92–95]. Hence, following SRP-dependent
delivery to the ER (cf. Fig. 2), membrane proteins des-
tined to assume a type III orientation do not employ
the canonical Sec61 translocon [97]. Rather, following
engagement of the SRP receptor, these nascent type
III TMPs can uniquely access the membrane insertase
activity of the EMC [96,97, our unpublished data]; an
action that may potentially be assisted by the Sec61
complex acting as a ribosomal docking site and/or via
Sec61-stimulated release of ribosome-nascent chains
from the SRP receptor (see [98]). Secondly, the EMC
acts as a chaperone/holdase for multi-span TMPs with
TMDs that contain suboptimal features [99–101].
Whilst some multi-span TMPs have cleavable ER
targeting signals (cf. Fig. 1B), many employ signal-an-
chor sequences to enable their SRP-dependent delivery
to the ER. These signal-anchor sequences form the
first TMD and, as for single-span TMPs (cf. Fig. 1B),
this sequence can be inserted into the ER membrane
either with its N terminus remaining in the cytosol
(type II-like, see Fig. 4) or with its N terminus translo-
cated into the lumen (type III-like, see Fig. 4). When a
type III-like multi-span TMP is truncated to enable
the membrane insertion of its first TMD to be studied
in isolation, its integration can be mediated by the
EMC alone [96]. Hence, TMDs that assume a type III
orientation, either in the context of a single-span TMP
or as the first TMD of a multi-span TMP, employ the
EMC for the membrane insertion. The ability of type
III and type III-like TMPs to access the membrane
insertase capacity of the EMC also provides a molecu-
lar level explanation of their unusual capacity to
bypass the otherwise extremely potent blockade of the
Sec61 translocon that can be achieved using small
molecule inhibitors such as ipomoeassin-F and myco-
lactone [97,102–105]. We also note that type III and
type III-like TMPs appear to show a reduced depen-
dence on Sec61 translocon gating assistants when com-
pared to obligate Sec61 clients (Fig. 3E, Table 5, cf.
secretory proteins, type I and type II TMPs versus
type III TMPs), further supporting their use of an
alternative site for translocation into and across the
ER membrane.
Whilst the precise molecular mechanisms that enable
the integration of type III and type III-like TMDs via
the EMC remain to be determined, a conserved hydro-
philic vestibule formed by the EMC3, EMC4 and
EMC6 subunits within the cytosolic side of the bilayer
is most likely its de facto insertase site [92–95]. Like
other members of the Oxa1 ‘superfamily’ of membrane
protein biogenesis factors [106,107], EMC3 is a struc-
tural homologue of YidC [95], a bacterial insertase
which acts downstream of SRP and whose flexible
cytosolic domains transiently contact SecY (a Sec61a
Table 1. Negatively affected secretory proteins and TMPs following Sec61 and accessory factor depletion; analysis of data presented in
Ref. [74]. Putative Sec63 clients that were identified in cells transiently depleted of Sec63 but not in Sec63 knockout cells are denoted in
brackets (X).
Uniprot ID Protein name Protein class Single/Multi Sec61A1 Sec62 Sec63 TRAP TMD number
Q10589 BST2 Type II TMP Single X X X 1
Q9H6E4 CCDC134 Secretory N/A X X X 0
O75503 CLN5 Type II TMP Single X X X 1
Q96HD1 CRELD1 Type I-like Multi X X X 2
Q9UBS4 DNAJB11 Secretory N/A X X (X) 0
Q9UM22 EPDR1 Secretory N/A X X X 0
Q96AY3 FKBP10 Secretory N/A X X 0
P06280 GLA Secretory N/A X X X 0
Q14554 PDIA5 Secretory N/A X X (X) 0
Q15262-2 PTPRK Secretory N/A X X X 0
Q9NXG6 P4HTM Type II TMP Single X X 1
O00584 RNASET2 Secretory N/A X X (X) 0
Q99470 SDF2 Secretory N/A X X (X) 0
Q9H173 SIL1 Secretory N/A X X (X) X 0
Q08357 SLC20A2 Type III-like Multi X X X 12
Q9ULF5 SLC39A10 Type III-like Multi X X X 7
O15533 TAPBP Type I Single X X 1
Q15582 TGFBI Secretory N/A X X 0
Q9Y3A6 TMED5 Type I Single X X (X) X 1
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Table 2. Negatively affected secretory proteins and TMPs in Sec62 knockout HeLa cells; analysis of data presented in Ref. [74]. Protein
substrates with an undefined topology of the 1st TMD (Uniprot) are in red.
Uniprot ID Protein name Protein class Single/Multi Sec61A1 Sec62 Sec63 TRAP TMD number
P11117 ACP2 Type I TMP Single X X 1
O14672 ADAM10 Type I TMP Single X X 1
P78536 ADAM17 Type I TMP Single X 1
P20933 AGA Secretory N/A X 0
Q9NRZ7 AGPAT3 Type II-like Multi X 2
Q9NRZ5 AGPAT4 Undefined Multi X X 4
Q8N6S5 ARL6IP6 Undefined Multi X X 3
Q86WA6 BPHL Secretory N/A X 0
Q10589 BST2a Type II TMP Single X X X 1
Q6Y288 B3GALTL Type II TMP Single X 1
P54289 CACNA2D1 Type I TMP Single X 1
Q8NFZ8 CADM4 Type I TMP Single X X 1
O43852-1 CALU Secretory Single X 0
O43852-4 CALU Secretory Single X 0
Q9H6E4 CCDC134a Secretory N/A X X X 0
Q9BWS9 CHID1 Secretory N/A X 0
O75503 CLN5 Type II TMP Single X X X 1
Q9H8M5 CNNM2 Type III-like Multi X X 4
P12109 COL6A1 Secretory N/A X X 0
P16870 CPE Secretory N/A X X 0
Q9H3G5 CPVL Secretory N/A X 0
Q96HD1 CRELD1a Type I-like Multi X X X 2
P07858 CTSB Secretory N/A X 0
P07339 CTSD Secretory N/A X 0
Q9UBR2 CTSZ Secretory N/A X 0
Q9UBS4 DNAJB11a Secretory N/A X X (X) 0
Q13217 DNAJC3 Secretory N/A X 0
Q9UM22 EPDR1a Secretory N/A X X X 0
Q9NZ08 ERAP1 Type II TMP Single X 1
Q96DZ1 ERLEC1 Secretory N/A X 0
Q9BS26 ERP44 Secretory N/A X 1
O75063 FAM20B Type II TMP Single X X 1
P98173 FAM3A Secretory N/A X 0
P26885 FKBP2 Secretory N/A X 0
Q9Y680 FKBP7 Secretory N/A X 0
Q96AY3 FKBP10a Secretory N/A X X 0
Q9NWM8 FKBP14 Secretory N/A X 0
P10253 GAA Secretory N/A X 0
Q14697-2 GANAB Secretory N/A X 0
Q92820 GGH Secretory N/A X 0
P06280 GLAa Secretory N/A X X X 0
P08236 GUSB Secretory N/A X X 1
P23229 ITGA6 Type I TMP Single X 1
Q14573 ITPR3 Type II-like Multi X 6
Q7Z4H8 KDELC2 Secretory N/A X 0
P49257 LMAN1 Type I TMP Single X 1
Q9UIQ6 LNPEP Type II TMP Single X X 1
Q8TDW0 LRRC8C Type II-like Multi X X 4
Q17RY6 LY6K Secretory N/A X X 0
Q14165 MLEC Type I TMP Single X 1
Q13724 MOGS Type II TMP Single X 1
P17050 NAGA Secretory N/A X 0
P13591 NCAM1 Type I TMP N/A X X 1
Q8TEM1 NUP210 Type I TMP Single X 1
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orthologue) during membrane protein insertion
[108,109]. By analogy with YidC, it may be envisaged
that an equivalent cytosolic region of EMC3, for
example the methionine-rich C1 loop and/or C termi-
nus [95], might somehow selectively capture type III
and/or type III-like TMDs and direct them towards
the EMC insertase site. We additionally speculate that,
as for YidC [110,111], positively charged regions
within one or more cytosolic domains may promote
RNC binding and thereby enable co-translational
insertion via the EMC. Like YidC and SecYEG in
bacteria [110], the EMC may support co-translational
membrane insertion both alone and when acting in
concert with the Sec61 complex. In the latter case, this
would provide a flexible site for the membrane inser-
tion of multi-span proteins containing closely spaced
TMDs with distinct requirements for Sec61 and EMC-
mediated integration (Fig. 4B; see also [83]).
The role of the EMC during the co-translational
biogenesis of multi-span TMPs is not strictly limited
to protein clients whose first TMD is type III-like
(Fig. 4A), additionally extending to the stabilisation
and/or insertion of downstream TMDs [99–
101,112,113] irrespective of the orientation of the first
TMD [89,90]. The decisive feature for the EMC-depen-
dence of these multi-span TMPs is reduced hydropho-
bicity and/or increased polarity or charge, as further
evidenced by the ability to create artificial EMC
dependency by introducing polar/charged residues into
a TMD [90,99,100]. Likewise, the observation that a
multi-span TMP containing such a suboptimal TMD
is diverted into to a pre-emptive ribosome quality con-
trol pathway in the absence of a functional EMC [114]
implicates the EMC in a chaperone-like protective role
akin to, but distinct from, that of the Sec61 translocon
(Fig. 4C) [115].
Informed by structural and functional studies [92–
97], we propose that, together, the Sec61 complex and
the EMC provide a flexible hub for co-translational
membrane insertion which can effectively mitigate the
potentially error-prone biogenesis of a diverse range of
client TMPs. We anticipate that future studies will
Table 2. (Continued).
Uniprot ID Protein name Protein class Single/Multi Sec61A1 Sec62 Sec63 TRAP TMD number
Q9UHG3 PCYOX1 Secretory N/A X 0
Q14554 PDIA5a Secretory N/A X X (X) 0
Q92508 PIEZO1 Undefined Multi X 36
O95427 PIGN Type II-like Multi X 15
Q8TEQ8 PIGO Undefined Multi X 14
Q8NBL1 POGLUT1 Secretory N/A X 0
P42785 PRCP Secretory N/A X 0
Q13162 PRDX4 Secretory N/A X 0
P14314 PRKCSH Secretory N/A X 0
Q13308-6 PTK7 Type I TMP Single X 1
P10586 PTPRF Type I TMP Single X 1
P23470 PTPRG Type I TMP Single X X 1
Q15262-2 PTPRKa Secretory N/A X X X 0
Q9NXG6 P4HTMa Type II TMP Single X X 1
Q15293 RCN1 Secretory N/A X 0
O00584 RNASET2a Secretory N/A X X (X) 0
Q9HB40 SCPEP1 Secretory N/A X 0
Q99470 SDF2a Secretory N/A X X (X) 0
P07093 SERPINE2 Secretory N/A X 0
P51688 SGSH Secretory N/A X 0
Q9H173 SIL1a Secretory N/A X X (X) X 0
Q08357 SLC20A2a Type III-like Multi X X X 12
Q9ULF5 SLC39A10a Type I-like Multi X X X 7
O15533 TAPBPa Type I TMP Single X X 1
Q9Y3A6 TMED5a Type I TMP Single X X (X) X 1
O14656 TOR1A Secretory N/A X 0
Q8NFQ8 TOR1AIP2 Type II TMP Single X 1
Q8NBZ7 UXS1 Type II TMP Single X X 1
Q9ULK5 VANGL2 Type II-like Multi X X 4
Q9BWQ6 YIPF2 Type II-like Multi X X 5
aProtein substrates that were also negatively affected following Sec61 depletion.
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Table 3. Negatively affected secretory proteins and TMPs in Sec63 knockout HeLa cells; analysis of data presented in Ref. [74]. Protein
substrates with an undefined topology of the 1st TMD (Uniprot) are in red.
Uniprot ID Protein name Protein class Single/Multi Sec61A1 Sec62 Sec63 TRAP
TMD
number
Q9NRZ5 AGPAT4 Undefined Multi X X 4
Q9H6U8 ALG9 Type III-like Multi X 8
Q9HDC9 APMAP Type II TMP Single X 1
Q8N6S5 ARL6IP6 Undefined Multi X X 3
P15848 ARSB Secretory N/A X 0
P98194-7 ATP2C1 Type II-like Multi X 10
Q10589 BST2a Type II TMP Single X X X 1
Q7KYR7 BTN2A1 Type I TMP Single X 1
Q8NFZ8 CADM4 Type I TMP Single X X 1
Q9H6E4 CCDC134a Secretory N/A X X X 0
Q4G0I0 CCSMST1 Type I TMP Single X 1
P13987 CD59 Secretory N/A X 0
Q8TCZ2 CD99L2 Type I TMP Single X 1
O75503 CLN5a Type II TMP Single X X X 1
P10909 CLU Secretory N/A X 0
Q9H8M5 CNNM2 Type III-like Multi X X 4
Q9BT09 CNPY3 Secretory N/A X 0
Q8NBJ5 COLGALT1 Secretory N/A X 0
P12109 COL6A1 Secretory N/A X X 0
P16870 CPE Secretory N/A X X 0
Q96HD1 CRELD1a Type I-like Multi X X X 2
P81605 DCD Secretory N/A X 0
P52429 DGKE Undefined Single X 1
Q9BW60 ELOVL1 Undefined Multi X 7
O75063 FAM20B Type II TMP Single X X 1
P06280 GLAa Secretory N/A X X X 0
Q68CQ7 GLT8D1 Type II TMP Single X X 1
Q70UQ0 IKBIP Type II TMP Single X 1
A1L0T0 ILVBL Undefined Single X 1
P53708 ITGA8 Type I TMP Single X 1
Q8TDW0 LRRC8C Type II-like Multi X X 4
Q6NSJ5 LRRC8E Type II-like Multi X 4
Q17RY6 LY6K Secretory N/A X X 0
Q9UKM7 MAN1B1 Type II Single X 1
Q8N4S9 MARVELD2 Type II-like Multi X 6
Q10469 MGAT2 Type II TMP Single X 1
P13591 NCAM1 Type I TMP Single X X 1
Q8N5Y8 PARP16 Type II TMP Single X 1
P23470 PTPRG Type I TMP Single X X 1
Q15262-1 PTPRK Type I TMP Single X 1
Q15262-2 PTPRKa Secretory N/A X X X 0
P02753 RBP4 Secretory N/A X 0
Q08357 SLC20A2a Type III-like Multi X X X 12
P46977 STT3A Type II-like Multi X 13
Q66K14 TBC1D9B Undefined Single X 1
Q9P2C4 TMEM181 Undefined Multi X 9
Q6ZXV5 TMTC3 Undefined Multi X 9
Q8N2C7 UNC80 Undefined Multi X 4
Q8NBZ7 UXS1 Type II TMP Single X X 1
Q9ULK5 VANGL2 Type II-like Multi X X 4
Q9BWQ6 YIPF2 Type II-like Multi X X 5
aProtein substrates that were also negatively affected following Sec61 depletion.
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Table 4. Negatively affected secretory proteins and TMPs in siRNA-mediated TRAP depleted HeLa cells; analysis of data presented in Ref.
[72]. Protein substrates with an undefined topology of the 1st TMD (Uniprot) are in red.
Uniprot ID Protein name Protein class Single/Multi Sec61A1 Sec62 Sec63 TRAP TMD number
P11117 ACP2 Type I TMP Single X X 1
O14672 ADAM10 Type I TMP Single X X 1
Q9BRR6 ADPGK Secretory N/A X 0
Q9NW15-2 ANO10 Type II-like Multi X 8
Q9H6X2 ANTXR1 Type I TMP Single X 1
Q9BXK5 BCL2L13 Undefined Single X 1
P08962 CD63 Type II-like Multi X 4
Q8N129 CNPY4 Secretory N/A X 0
P08572 COL4A2 Secretory N/A X 0
O75629 CREG1 Secretory N/A X 0
O00622 CYR61 Secretory N/A X 0
P61803 DAD1 Type II-like Multi X 3
P39656 DDOST Type I TMP Single X 1
O15121 DEGS1 Undefined Multi X 6
P00533 EGFR Type I TMP Single X 1
Q9UM22 EPDR1a Secretory N/A X X X 0
P02751 FN1 Secretory N/A X 0
Q68CQ7 GLT8D1 Type II TMP Single X X 1
Q5VW38-2 GPR107 Type I-like Multi X 7
P08236 GUSB Secretory N/A X X 0
Q8TCT9 HM13 Type III-like Multi X 9
P56937 HSD17B7 Type III TMP Single X 1
P08069 IGF1R Type I TMP Single X 1
P06756 ITGAV Type I TMP Single X 0
Q8IWB1 ITPRIP Type I TMP Single X 1
Q08380 LGALS3BP Secretory N/A X 0
Q12907 LMAN2 Type I TMP Single X 1
Q9UIQ6 LNPEP Type II TMP Single X X 1
Q643R3 LPCAT4 Undefined Multi X 2
Q9H0U3 MAGT1 Type I TMP Single (X) X 1
Q8NHP6 MOSPD2 TA protein Single X 1
P15941 MUC1 Type I TMP Sinle X 1
P54802 NAGLU Secretory N/A X 0
Q969V3 NCLN Type I TMP Single X 1
Q9UMX5 NENF Secretory N/A X 0
Q99519 NEU1 Secretory N/A X 0
Q5JPE7 NOMO2 Type I TMP Single X 1
H0Y858 N/A Type I TMP Single X 1
Q96E52 OMA1 Undefined Single X 1
Q9UBV2 SEL1L Type I TMP Single X 1
Q13214 SEMA3B Secretory N/A X 0
Q9H173 SIL1a Secretory N/A X X (X) X 0
P11166 SLC2A1 Type II-like Multi X 12
Q8TB61 SLC35B2 Undefined Multi X 9
Q9ULF5 SLC39A10a Type III-like Multi X X X 7
P04920 SLC4A2 Type II-like Multi X 11
P35610 SOAT1 Type II-like Multi X 9
Q15005 SPCS2 Type II-like Multi X 2
Q8TCJ2 STT3B Type II-like Multi X 13
Q15582 TGFBIa Secretory N/A X X 0
P55061 TMBIM6 Type II-like Multi X 7
Q9Y3A6 TMED5a Type I TMP Single X X (X) X 1
Q6UW68 TMEM205 Undefined Multi X 4
A0PJW6 TMEM223 Undefined Multi X 2
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establish how individual TMDs are directed to either
the EMC or Sec61 complex as appropriate, how the
EMC governs TMD release into the membrane and
further explore the regulation and potential interplay
between the insertase activity of the EMC and its role
as a chaperone/holdase. Given that EMC disruption
negatively affects the levels of several secretory pro-
teins [89], some of which also require Sec62 and/or
TRAP (Fig. 4A) [72,74], we speculate that Sec61
dgating assistants and/or the EMC may also exert
some, as yet undefined, regulatory role during Sec61-
mediated co-translational translocation. Likewise, how
the actions of this Sec61/EMC membrane insertion
hub are co-ordinated with other recently identified
TMD insertases/assemblases such as TMCO1 and the
PAT complex (see New routes for insertion and fold-
ing: TMCO1 and the PAT complex) and various mem-
brane protein complexes responsible for co-
translational modifications including N-glycosylation
(for a review see [9]) is a fascinating question.
New routes for insertion and folding:
TMCO1 and the PAT complex
TMCO1 belongs to the same family of membrane pro-
tein insertases as EMC3/YidC (see [95,106,107]), and it
can transiently associate with the ribosome-bound
Sec61 complex [117]. In addition to the Sec61 complex,
TMCO1 associates with CCDC47 [118] and the Nica-
lin-TMEM147-NOMO complex [119] to form a higher
order collective referred to as the ‘TMCO1 translocon’
(Fig. 4A), which is implicated in the biogenesis of mul-
tispan TMPs [117]. Like the EMC, the TMCO1
translocon appears widely conserved and its disruption
leads to reduced cellular fitness [120] and various
organismal phenotypes [117,121]. Thus, although the
precise biochemical function of the TMCO1 translocon
remains unclear, structural and functional analogy
with the EMC suggest that it may integrate insuffi-
ciently hydrophobic TMDs alone. Alternatively, given
its association with the active Sec61 complex, it might
assist the ‘core’ Sec61 translocon with the membrane
insertion of suboptimal TMDs and/or help to shield
newly integrated TMDs during the biogenesis and
assembly of multi-span TMPs [117]. As with the EMC,
we anticipate that a fuller understanding of TMCO1
protein clients, together with high-resolution structures
of Sec61-TMCO1 bound RNCs, will be required to
provide a unifying model for the concerted actions of
the Sec61 and TMCO1 complexes. Despite clear paral-
lels between the EMC and TMCO1 complex, including
their potential dual activities as both a TMD insertase
and chaperone/holdase [92,117], one feature firmly sets
them apart; subunits of the TMCO1 translocon do not
stably associate in the absence of ribosomes [117].
Thus, unlike the EMC, the TMCO1 translocon
appears to exist as a short-lived entity that transiently
assembles and disassembles according the needs of the
Sec61 complex and the RNCs that it is presented with.
The availability of TMCO1 subunits for transient
assembly into the TMCO1 translocon may also be reg-
ulated by ER calcium levels. Hence, TMCO1 subunits
homotetramerise to form calcium release channels in
response to critically high levels of ER lumenal cal-
cium, but rapidly disassemble once calcium levels are
restored [121].
Structural evidence that the EMC has distinct TMD
chaperone and TMD insertase activities is only begin-
ning to emerge [92]. However, a protein complex that
acts as a bona fide chaperone for TMDs that have
exited the Sec61 translocon has recently been identi-
fied, firmly establishing the physiological necessity of
such components [122]. The existence of the PAT com-
plex was first apparent from in vitro studies of multi-
span TMP biogenesis, which characterised a
component named PAT10 [123]. Following its lateral
exit from the Sec61 translocon, the first TMD of a
model multi-span TMP was shown to next encounter
PAT10 and remain associated with this component as
subsequent TMDs from the same nascent multi-span
TMP were integrated via the Sec61 complex [123–125].
Only now do we know that PAT10 is in fact a protein
Table 4. (Continued).
Uniprot ID Protein name Protein class Single/Multi Sec61A1 Sec62 Sec63 TRAP TMD number
Q8N2U0 TMEM256 Type III-like Multi X 2
O14773 TPP1 Secretory N/A X 0
Q15629 TRAM1 Type II-like Multi X 8
Q13454 TUSC3 Type I-like Multi X 4
Q9GZX9 TWSG1 Secretory N/A X 0
Q5T9L3 WLS Type II-like Multi X 8
P41221 WNT5A Secretory N/A X 0
aProtein substrates that were also negatively affected following Sec61 depletion.
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called Asterix, which forms an obligate heterodimer
with CCDC47 that has been termed the PAT complex
[122] (Fig. 5B). Most significantly, the PAT complex
chaperones the assembly of multi-span TMPs, acting
after their TMDs are inserted into the membrane but
before protein folding is complete (Fig. 5C) [122]. Fur-
thermore, whilst the substrate-binding Asterix subunit
co-translationally engages membrane inserted TMDs
with charged/polar residues that are exposed to the
lipid bilayer, the PAT complex may remain associated
with client TMDs even after translation termination,
effectively shielding suboptimal TMDs until they are
correctly packed into a natively structured multi-span
TMP [122–124]. Interestingly an earlier genome-wide
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screen had implicated both Asterix (also known as
WDR83OS) and hSnd2 (see ER membrane targeting:
the SRP-delivery system) in the biogenesis of multi-
span TMPs [52].
Significantly, both the apparent preference of the
PAT complex for TMDs of a more hydrophilic nature
and its ability to engage TMDs irrespective of their
transmembrane orientation [122,123] mirror the chap-
erone/holdase activity of the EMC (cf. Fig. 4). Fur-
thermore, at least some multi-span TMPs that are
dependent on the insertase activity of the EMC also
require the PAT complex in order to assume a native
conformation [122]. However, the EMC does not com-
pensate for loss of the PAT complex, whilst the depen-
dence of a TMP client on the PAT complex is
unaffected if the EMC is bypassed during membrane
insertion [122], suggesting that any functional redun-
dancy between the two complexes is limited. Rather, it
seems likely that the molecular basis for TMD recogni-
tion by each complex is sufficiently distinct that speci-
fic protein clients are able to access the chaperone
activity of one complex whilst being precluded from
engaging with the other (Fig. 5C). In the case of
TMDs that are inserted via the Sec61-containing
TMCO1 translocon, one possibility is that hydrophilic
TMDs may be sequentially handed over to the PAT
complex until the assembly of a multi-span TMP is
complete (Fig. 5C) [126]. In this scenario, the interac-
tion of CCDC47 with the Sec61-bound ribosome near
its exit tunnel could provide an important physical link
that enables client TMDs to access the substrate-bind-
ing Asterix subunit of the PAT complex. However, it
should be noted that at present there is no direct evi-
dence that TMCO1-associated CCDC47 is also in
complex with Asterix [117,126].
Whether or not Asterisk is an as yet unidentified
component of the TMCO1 translocon, or specific to a
distinct PAT complex (Fig. 5A,B), is an urgent ques-
tion that needs to be addressed. Likewise, determining
how specific TMDs are directed to the PAT complex,
how it helps these proteins assemble into a native fold
and how correctly folded TMPs are eventually
released, are all key steps towards fully understanding
exactly how these recently identified Sec61 assistants
contribute to the biogenesis of multi-span TMPs.
Given that CCDC47 was named calumin on the basis
of its calcium binding properties [127], and that cal-
cium levels affect the homomerisation state of the
TMCO1 subunit [121], the possibility that calcium
levels might influence the biogenesis of multi-span
TMPs via CCDC47 and/or the TMCO1 subunit
should also be considered (for a review see [128]).
Concluding remarks: where do we go
from here?
Over the past few years, our understanding of the
molecular machineries that can be recruited by, and in
at least one case completely bypass, the core Sec61
complex has skyrocketed. Various studies have rede-
fined the roles of cytosolic components, including NAC
and SGTA, during co-translational TMP biogenesis at
the ER, discovered new routes for TMD insertion via
the EMC and TMCO1 translocon, and identified the
Fig. 4. The role of the EMC in co-translational integration: two sides of the same coin (A) Schematics of the human EMC depicting its
tripartite organisation in the ER membrane: a basket-shaped cytosolic region comprised of EMC2 and either of the functional paralogues
EMC8 or EMC9; a membrane spanning core containing both gated and lipid-filled membrane cavities; and an L-shaped ER lumenal domain
comprised of EMC1, EMC7 and EMC10 [92,94,95]. The insertase site formed by EMC3/EMC4/EMC6 is near the cytosolic vestibule, whilst
the hydrophobic cleft may have a role in client TMD capture [92,94,95]. EMC subunits identified as structurally integral are based on
depletion studies of individual subunits which destabilise the wider EMC complex [116] and the classification of EMC subunits relies on
structural studies and/or topology prediction software, with the topology of EMC4 remaining ambiguous and that of EMC6 dependent on its
assembly with EMC5 [92,94,95]. (Aii) The types of potential client proteins that were negatively affected using a mass-spectrometry-based
proteomic approach in EMC2, EMC4 and EMC6 knockout HeLa cells are indicated [89,90]. The percentage of each substrate class is shown
relative to the total number of putative EMC clients (n = 58) in the combined datasets [89,90], clearly illustrating that the majority of EMC
clients are multi-span proteins. In a small number of cases, EMC clients are also dependent on Sec62 and/or TRAP as indicated [72,74]; see
also Fig. 3E, Table 5). Proteins that do contain an ER targeting signal were discounted for the purposes of this analysis. (B) A unifying
model for the co-translational insertion of type III TMPs whereby, following presumed SRP-dependent targeting to the ER membrane, the
noncanonical Sec61 complex supports the insertase activity of the EMC via its gated cavity in some way [92, 97, our unpublished data]. As
suggested for TMD1 of type III-like multi-span TMPs [96], and analogous to the bacterial insertase YidC, co-translational TMD insertion may
also be facilitated by the EMC acting alone. These depictions are not representative of the relative orientations of Sec61, the EMC and the
RNC which are currently unknown, although it has been proposed that the minimum distance from the Sec61 lateral gate to the membrane
spanning core of the EMC is ~ 110 A [94]. (C) The chaperone/holdase activity of the EMC, which stabilises and/or inserts suboptimal TMDs
of multi-span TMPs, manifests via the lipid cavity [92]. Absence of a functional EMC leads to defective TMD handling resulting in the
degradation of multi-span TMPs via a pre-emptive ribosome-associated quality control pathway [114]. TIC, translation initiation complex.
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Fig. 5. TMCO1 translocon and PAT complex: one or two more Sec61-assistants for multi-span TMPs? (A) Schematics of the TMCO1
translocon and the topologies and domain structures of each subunit [117]: TMEM147 is the core subunit of the Nicalin-TMEM147-NOMO
complex [119] which, when assembled into the Sec61-TMCO1-RNC complex (NOMO not depicted), lines a lipid cavity at the centre of this
transient complex. (B) The CCDC47 and Asterix subunits of the PAT complex form a stable heterodimer [122], but its precise relationship to
the TMCO1 translocon, if any, is unclear [126]. Based on its proximity to the ribosomal exit tunnel [117], CCDC47 may be able to sense
hydrophilic TMD residues and recruit Asterix into the wider TMCO1 complex. Alternatively, the PAT complex may function as an
independent entity, closely associated with the Sec61 complex [123], that shields and assembles TMDs following their initial membrane
insertion [122]. (C) A snapshot of multi-span TMP biogenesis at the ER. Following SRP-dependent targeting, TMPs may access the ER
membrane via a Sec61-mediated pathway, a Sec61/EMC-mediated pathway or a TMCO1 translocon-mediated pathway. Irrespective of the
initial mechanism of TMD integration in the ER membrane, the PAT complex can associate with membrane inserted TMDs that would
otherwise expose polar residues to the lipid bilayer, and chaperone them until they can be assembled with other TMDs to form a stable
multi-span TMP.
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PAT complex as a TMD chaperone and assemblase.
Likewise, we now understand that Sec62, Sec63 and the
TRAP complex modulate and enhance the capabilities
of the core Sec61 translocon in order to expand its cli-
ent base. When all of these elements are taken together,
they provide an amazingly flexible platform that is cap-
able of synthesising an incredibly diverse and challeng-
ing range of secretory and TMP clients. On the basis of
our current understanding, we propose that the Sec61
complex provides the central component of this flexible
platform, acting as a dynamic hub for membrane
translocation at the ER. This begs the question as to
how alternative membrane insertion pathways or partic-
ular Sec61-assistants are engaged by different client
TMPs and how their actions can be co-ordinated; a feat
that becomes increasingly complex when one considers
the recent finding that both homomeric and heteromeric
TMP complexes can begin their assembly co-transla-
tionally [129,130].
Another important contribution to our increased
knowledge and understanding of TMP biogenesis has
been the discovery and characterisation of small mole-
cules and toxins, which selectively inhibit the Sec61
translocon [131–133]. Hence, via the study of individ-
ual proteins [6,97,104] together with a global pro-
teomics-based approach [103], it was the resistance of
type III and type III-like TMPs to such compounds
which revealed a previously unanticipated level of
complexity that was incompatible with the prevailing
models of TMP biogenesis [7,8,83]. Given that many
of the TMP clients of the Sec61 complex are drug tar-
gets [133], Sec61 inhibitors are promising candidates
for therapeutic development; particularly since they
appear well tolerated in vivo [134–137] and have
demonstrated promising analgesic [134], antibacterial
[138], anti-inflammatory [135], antitumour [136] and
antiviral [139–141] activity.
As evidenced by studies of proteins from influenza
and SARS-CoV-2 viruses, the antiviral activity of these
compounds typically relies on their host-targeted inhi-
bition of the canonical Sec61 translocon, effectively
blocking the biogenesis of important viral proteins at
the host cell ER [97,103]. Dengue and Zika viruses
likewise co-opt the TMP biosynthetic machinery of the
host cell ER [141], whilst cell-based studies of influen-
za, HIV and dengue have firmly established proof of
concept for the inhibition of viral growth and propa-
gation through the selective perturbation of Sec61-me-
diated protein translocation [139]. Thus, Sec61
inhibitors may provide one route for developing much
needed broad-spectrum agents that can be mobilised
against many different viruses [142]. Likewise, the dis-
covery of the EMC, TMCO1 translocon and PAT
complex make them valid candidates for developing
complementary small molecule inhibitors which target
the biogenesis of specific classes and/or groups of
TMPs at the ER. In short, as we gain more insight
into the components, pathways and molecular mecha-
nisms utilised by our cells to create functional mem-
brane proteins, this knowledge will in turn present us
with new and exciting opportunities to modulate these
processes for the benefit of human health [143,144].
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